Menu
Search
|

Menu

Close
X

Sensus Healthcare Inc SRTS.OQ (NASDAQ Stock Exchange Capital Market)

5.74 USD
+0.02 (+0.35%)
As of 2:29 AM IST
chart
Previous Close 5.72
Open 5.66
Volume 288
3m Avg Volume 2,121
Today’s High 5.74
Today’s Low 5.66
52 Week High 6.05
52 Week Low 3.52
Shares Outstanding (mil) 13.49
Market Capitalization (mil) 71.36
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY17
21
FY16
15
FY15
10
EPS (USD)
FY17
-0.280
FY16
-0.031
FY15
-0.063
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
4.07
5.77
Price to Book (MRQ)
vs sector
5.55
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
11.27
16.52
LT Debt to Equity (MRQ)
vs sector
0.00
12.22
Return on Investment (TTM)
vs sector
-16.78
14.43
Return on Equity (TTM)
vs sector
-16.80
16.13

EXECUTIVE LEADERSHIP

Joseph Sardano
Chairman of the Board, Chief Executive Officer, Since 2010
Salary: $272,475.00
Bonus: $55,000.00
Kalman Fishman
Co-Founder, Chief Operating Officer, Chief Technology Officer, Since
Salary: $189,000.00
Bonus: $57,800.00
Richard Golin
Co-Founder, Executive Vice President - Sales, Oncology and International, Since
Salary: --
Bonus: --
Arthur Levine
Chief Financial Officer, Since 2014
Salary: $160,000.00
Bonus: $48,000.00
Stephen Cohen
Senior Vice President - Strategic Initiatives and Dermatology, Since 2010
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

851 Broken Sound Pkwy NW Ste 215
BOCA RATON   FL   33487-3635

Phone: +1561.9225808

Sensus Healthcare, Inc., formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The superficial radiation therapy is an alternative to surgical basal cell carcinoma treatment and squamous cell carcinoma treatment. The Company's product, the SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions, such as keloids. The SRT-100 treats primary lesions that would otherwise be difficult or require surgery involving sensitive areas of the head and neck regions, such as the fold in the nose, eyelids, lips, corner of the mouth and the lining of the ear.

SPONSORED STORIES